AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.
Forex – financial instrument.Forex news
AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.